Liu, Xue

7Lunan Pharmaceutical Group Co., LTD, Linyi, China

1 paper on CoChat

Most cited papers

Verified
A Phase 1 First-in-Human Monotherapy Study of F182112, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory Multiple Myeloma
Sun, M., Qi, J., Qiu, L., Jin, J., Li, X., Wei, Y., Zhang, G., Liu, X., & Yin, S. (2023) · Blood
Multiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research
Cited by 5

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free